Company / PP&E (Net)
Surgery Partners, Inc. PP&E (Net) History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$1.1B
FY2024
5-year range
$544.6M / $1.1B
FY2020-FY2024
Trend
+12.3%
vs FY2023
Sector context
#36 of 132
Health Care
What the data says
At $1.1B, Surgery Partners, Inc.'s pp&e (net) ranks #36 of 132 in the Health Care sector. PP&E (Net) has increased for 6 consecutive years, from $426M in FY2018 to $1.1B in FY2024.
Based on SEC 10-K filings.
$1.1B in FY2024 with a 5-year CAGR of +15.8%.
Improved from $877M to $1.1B over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +20.0%
- 5-Year CAGR
- +15.8%
- 10-Year CAGR
- -
Sector benchmark
#36 of 132 in Health CareTop 27% of 132This company $1.1B Sector average $1.4B
▼
-24.2% below sector average
Key checks
Key Insights
- Surgery Partners, Inc.'s pp&e (net) has grown for 6 consecutive years.
- 5-year CAGR of +15.8%, indicating consistent growth.
- In FY2024, pp&e (net) increased 12.3% year-over-year.
- Ranks #36 out of 132 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.31 (distress zone, below 1.8 threshold)
- Negative profit margin: -14.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.1B | +12.3% |
| FY2023 | $968.7M | +10.5% |
| FY2022 | $876.6M | +39.2% |
| FY2021 | $629.7M | +15.6% |
| FY2020 | $544.6M | +4.1% |
| FY2019 | $523.3M | +22.8% |
| FY2018 | $426.3M | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026